Ambulatory disability and older age are associated with worse clinical severity of COVID-19, including death, among patients with multiple sclerosis (MS), according to a study published online March 19 in JAMA Neurology. Amber Salter, Ph.D., from the Washington University School of Medicine in St. Louis, and colleagues examined outcomes and risk factors associated with COVID-19 clinical severity in a cohort of 1,626 patients with MS.
